About this episode
FTX Testimony and Moderna's New Drug (Podcast)Mike McGlone, Senior Commodity Strategist with Bloomberg Intelligence, and Nathan Dean, Senior Policy Analyst, US and Latin America with Bloomberg Intelligence, and Katie Greifeld, cross asset reporter with Bloomberg News, join the show to discuss outlook for crypto coins and crypto policy in DC ahead of the testimony of FTX's new CEO. Moderna CEO Stephane Bancel discusses the company's skin cancer drug breakthrough. Annie Massa, cross asset reporter with Bloomberg News, and Barry Ritholtz, host of Bloomberg's "Masters in Business," join to discuss the FTX testimony on Capitol Hill. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.
Get every episode summarized
Each time Bloomberg Intelligence publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Bloomberg Intelligence
GE to Buy Consolidated Precision Products for $11.75 Billion
Bloomberg Intelligence
Introducing: Bloomberg Money
Bloomberg Intelligence
Bloomberg Money: Premium Travel, Fast Fashion, Luxury at the US Open & The Cost...
Bloomberg Intelligence
Anthropic Finalizing $15 Billion Pre-IPO Credit Facility
Bloomberg Intelligence